Newsroom

Biotechnology

Explore the latest breakthroughs and trends in the Biotechnology sector with our newsroom. From cutting-edge innovations in gene therapy and biopharmaceuticals to advancements in medical research and regulatory updates, we provide essential insights into the scientific developments shaping the future of healthcare and life sciences.


Latest Press Releases

Molecular Partners’ R&D Day in New York highlights progress of pipeline of DARPin® therapeutic candidates and dedicated research focus areas
Biotechnology

Molecular Partners’ R&D Day in New York highlights progress of pipeline of DARPin® therapeutic candidates and dedicated research focus areas

December 6, 2018 1:00 AM

The company announces plans to launch a second phase 2 clinical trial in multiple myeloma with MP0250, its proprietary lead asset in oncology Pamela Trail, the company's new CSO, highlights progress focusing the research team in several key areas, with the goal of producing a sustainable pipeline of DARPin® molecule IND candidates The company provides additional insight on its...

Read more
EastWest Bioscience Continues Expansion on the Canadian East Coast Through Agreement with Largest Pet Chain in Quebec
Biotechnology

EastWest Bioscience Continues Expansion on the Canadian East Coast Through Agreement with Largest Pet Chain in Quebec

December 5, 2018 1:35 PM

VANCOUVER, BC / ACCESSWIRE / December 5, 2018 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) announces that it will soon have its premium pet brand Natural Pet Science available for purchase at Mondou, the largest pet retail chain in Quebec. Having the Natural Pet Science products available at Mondou is within Eastwest's overall sales strategy to expand its retail distribution across Canada toward the country's East Coast...

Read more
American CryoStem Receives Final Patent to Complete its Core Cellular Platform
BiotechnologyCompany Update

American CryoStem Receives Final Patent to Complete its Core Cellular Platform

December 4, 2018 6:00 AM

EATONTOWN, NJ / ACCESSWIRE / December 4 , 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular products and technologies for the Regenerative and Personalized Medicine industries, today announced receipt from the USPTO of the Issue Notification for our Patent titled ''Systems and Methods for the Digestion of Adipose Tissue Samples from a Client...

Read more
PCT LTD Announces Successful Presentation of Annihilyzer(R) Hospital Infection Control Systems at APIC Event in South Carolina
Biotechnology

PCT LTD Announces Successful Presentation of Annihilyzer(R) Hospital Infection Control Systems at APIC Event in South Carolina

November 29, 2018 7:30 AM

LITTLE RIVER, SC / ACCESSWIRE / November 29, 2018 / PCT LTD (OTC Pink: PCTL), a leader in environmentally safe, non-toxic, antimicrobial solutions for infection control, recently attended the South Carolina Association for Professionals in Infection Control and Epidemiology (APIC) event in Columbia, SC. PCT introduced attendees to the new Annihilyzer® Infection Control System during the event. The response from the attendees was positive and...

Read more
Quanta Inc. to Present at the 11th Annual LD Micro Main Event
Biotechnology

Quanta Inc. to Present at the 11th Annual LD Micro Main Event

November 28, 2018 11:00 AM

LOS ANGELES, CA / ACCESSWIRE / November 28, 2018 / Quanta Inc. (OTC PINK: QNTA), an applied bio-science company announced today that it will be presenting at the 11th Annual LD Micro Main Event. The conference is being held on December 4-6, 2018 at the Luxe Sunset Blvd Hotel in Los Angeles. Event: 11th Annual LD Micro Main Event Location: Luxe Sunset Blvd Hotel, Los Angeles Date: December 5, 2018 -- 2:00 PM PST Mr. Eric Rice, CEO and Founder of...

Read more
Pressure BioSciences Expands on Recent Achievement of Major Development Milestones in Ultra Shear Technology for Diverse High Value Products, Including CBD Oil
BiotechnologyCompany Update

Pressure BioSciences Expands on Recent Achievement of Major Development Milestones in Ultra Shear Technology for Diverse High Value Products, Including CBD Oil

November 28, 2018 9:05 AM

Interviewing with Proactive Investors, CEO Richard T. Schumacher Also Highlights and Accentuates Importance of Timely Appointment of Dr. Brad Young as Chief Commercial Officer SOUTH EASTON, MA / ACCESSWIRE / November 28, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life...

Read more
AzurRx BioPharma to Present at the 11th Annual LD Micro Main Event
BiotechnologyConferences

AzurRx BioPharma to Present at the 11th Annual LD Micro Main Event

November 28, 2018 8:00 AM

NEW YORK, NY / ACCESSWIRE / November 28, 2018 / AzurRx BioPharma, Inc. (NASDAQ: AZRX) (''AzurRx'' or the ''Company''), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, announced that it will be presenting at the 11th Annual LD Micro Main Event on Thursday, December 6th at 8:00 AM PST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Thijs Spoor, Chief Executive Officer, and...

Read more
Pressure BioSciences Achieves Second Major Milestone in the Development of Its Ultra Shear Technology Platform
BiotechnologyInvestor Relations

Pressure BioSciences Achieves Second Major Milestone in the Development of Its Ultra Shear Technology Platform

November 15, 2018 12:10 PM

Company Announces Successful Development of Proprietary Method for High Quality, Water Soluble Oils, Opening Major New Opportunities in Multiple Markets; Initial Focus to be in the CBD Oil and Cosmetics Markets SOUTH EASTON, MA / ACCESSWIRE / November 15, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform...

Read more
Pressure BioSciences, Inc. Reports Third Quarter and YTD 2018 Financial Results and Provides Business Update
BiotechnologyEarnings

Pressure BioSciences, Inc. Reports Third Quarter and YTD 2018 Financial Results and Provides Business Update

November 14, 2018 6:30 PM

Significant Operating Loss Decrease, Initial Revenue from New Scientific Services Group, and Accelerated Development of Ultra Shear Technology Platform Highlight Q3 and YTD Results SOUTH EASON, MA / ACCESSWIRE / November 14, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide life...

Read more
Neocis Inc. Reaches First Commercial Milestone for Yomi(R) - The World's First Robot-Assisted Dental Surgical System
BiotechnologyCompany Update

Neocis Inc. Reaches First Commercial Milestone for Yomi(R) - The World's First Robot-Assisted Dental Surgical System

November 14, 2018 9:45 AM

MIAMI, FL / ACCESSWIRE / November 14, 2018 / Neocis, Inc., the leader and innovator in dental implant surgery utilizing advanced robotics, announced today that it reached its first U.S. commercialization milestone with the sale of its 20th Yomi® surgical system. "Following FDA clearance, we launched the 'Pioneer Program' in the U.S. to attract early adopters. I'm extremely pleased with the commercial adoption this program received, enabling us...

Read more
Pressure BioSciences, Inc. to Discuss Third Quarter 2018 Financial Results and Provide Business Update
Biotechnology

Pressure BioSciences, Inc. to Discuss Third Quarter 2018 Financial Results and Provide Business Update

November 14, 2018 7:11 AM

Conference Call Scheduled for Wednesday, November 14th at 4:30 PM EST SOUTH EASTON, MA / ACCESSWIRE / November 14, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2018 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by telephone...

Read more
Mymetics Presents New Data Regarding Cold Chain Independent Virosome Based Vaccines
Biotechnology

Mymetics Presents New Data Regarding Cold Chain Independent Virosome Based Vaccines

November 14, 2018 5:35 AM

EPALINGES, SWITZERLAND / ACCESSWIRE / November 14, 2018 / Mymetics Corporation (OTCQB: MYMX), a pioneer and leader in the research and development of virosome-based vaccines against life-threatening and life disabling diseases, announces that new data is presented today by Mymetics at the annual Mucosal Vaccines, Adjuvants and Delivery meeting in Lausanne, Switzerland. Since 2015, Mymetics has been leading a consortium to develop thermostable...

Read more
ABMC Reports Third Quarter 2018 Results
BiotechnologyEarnings

ABMC Reports Third Quarter 2018 Results

November 13, 2018 2:30 PM

KINDERHOOK, NY / ACCESSWIRE / November 13, 2018 / American Bio Medica Corporation (OTC PINK: ABMC) today announced financial results for the three and nine months ended September 30, 2018. Chief Executive Officer Melissa A. Waterhouse stated, "Although sales declined in the third quarter of 2018 when compared to the third quarter of 2017, we are still expecting new relationships/contracts to positively impact sales going forward into 2019. One...

Read more
Zivo Claims Gras Status for its Proprietary Algal Biomass, Allowing Immediate Marketing of its Premiere Product as a Human Food Ingredient
BiotechnologyInvestor RelationsRegulatory

Zivo Claims Gras Status for its Proprietary Algal Biomass, Allowing Immediate Marketing of its Premiere Product as a Human Food Ingredient

November 12, 2018 9:00 PM

KEEGO HARBOR, MI / ACCESSWIRE / November 12, 2018 / ZIVO Bioscience, Inc. (OTCMKTS: ZIVO) a biotech/agtech R&D company engaged in the commercialization of nutritional products derived from its proprietary algal strains, announces today that it has received notice from an independent scientific review panel that ZIVO has satisfied the safety and process requirements to affirm GRAS status for its proprietary Kalgae™ branded dried algal biomass....

Read more
Pressure BioSciences Achieves Major Milestone  in the Development of its Ultra Shear Technology Program
BiotechnologyCompany Update

Pressure BioSciences Achieves Major Milestone in the Development of its Ultra Shear Technology Program

November 9, 2018 11:50 AM

Company Completes Development of First Working Prototype of UST System and Initiates Program to Develop Proprietary Method to Make Water Soluble Oils for Use in Multiple Markets SOUTH EASTON, MA / ACCESSWIRE / November 9, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide...

Read more
Dyadic International Reports Third Quarter 2018 Financial Results
BiotechnologyCompany Update

Dyadic International Reports Third Quarter 2018 Financial Results

November 7, 2018 4:30 PM

Initial registration statement on Form 10 filed with the SEC Fully funded proof of concept research collaboration signed with Sanofi-Aventis Deutschland GmbH Progress in productivity and stability in Company’s research programs JUPITER, FL / ACCESSWIRE / November 7, 2018 / Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to...

Read more
Qrons Enters into Placenta Sourcing Agreement under the Declaration of Helsinki
BiotechnologyCompany Update

Qrons Enters into Placenta Sourcing Agreement under the Declaration of Helsinki

November 7, 2018 11:45 AM

Agreement Will Facilitate Completion of First Prototype Product MIAMI, FL / ACCESSWIRE / November 7, 2018 / Qrons Inc. (OTC PINK: QRON) ("Qrons" or the "Company"), a preclinical biotechnology company developing advanced cell-based solutions to combat neuronal injuries with a laser focus on treating traumatic brain injuries ("TBIs"), announced today that it has entered into an Agreement with Meir Hospital in Israel to obtain a reliable source of...

Read more
Bradford A. Young, Ph.D., MBA Joins Pressure BioSciences as Chief Commercial Officer
BiotechnologyCompany Update

Bradford A. Young, Ph.D., MBA Joins Pressure BioSciences as Chief Commercial Officer

November 7, 2018 9:45 AM

With Academic and Industry Experience Spanning 25 Years, Dr. Young Will Combine Exceptional Industry, Business, and Marketing Skills with Strong Technical and Leadership Experience to Help Drive Product Adoption and Accelerate Revenue Growth SOUTH EASTON, MA / ACCESSWIRE / November 7, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (''PBI'' or the ''Company''), a leader in the development and sale of broadly enabling, pressure-based instruments,...

Read more
Molecular Partners to Present New Data on Immuno-Oncology Pipeline at Upcoming Scientific Conferences
Biotechnology

Molecular Partners to Present New Data on Immuno-Oncology Pipeline at Upcoming Scientific Conferences

November 6, 2018 12:36 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / November 6, 2018 / Molecular Partners AG (SWX: MOLN), a clinical-stage biopharmaceutical company pioneering the use of DARPin® therapeutics* to treat serious diseases, today announced that the company plans to participate in several upcoming scientific conferences in November and December 2018. At these conferences listed below, members of the Molecular Partners team will present updated research and...

Read more
VTT and Dyadic International to Present Data on C1 Protein Platform at AAPS PharmSci 360 and PEGS Europe
BiotechnologyCompany Update

VTT and Dyadic International to Present Data on C1 Protein Platform at AAPS PharmSci 360 and PEGS Europe

November 5, 2018 9:45 AM

Data Demonstrate C1 Can Be Developed Into a New-Generation Therapeutic Protein Production System ESPOO, FINLAND and JUPITER, FL / ACCESSWIRE / November 5, 2018 / VTT Technical Research Centre of Finland Ltd (''VTT'') and Dyadic International, Inc. (OTCQX: DYAI)(''Dyadic'') will present data on the companies' ongoing R&D collaboration involving Dyadic's C1 Myceliophthora thermophila fungal strain at: AAPS PharmSci 360 in Washington, DC on...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?